Australia says CSL unit Seqirus to discontinue Benpen injections from November
Australia's drug regulator said on Wednesday it was notified by biopharmaceutical giant CSL's unit Seqirus that it will be discontinuing all strengths of their Benpen injection products progressively due to commercial reasons.
CSL's vaccine arm notified the regulator that the discontinuation will start with the 600 milligrams (mg) strength from 30 November 2026.
(Reporting by Shivangi Lahiri in Bengaluru)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published May 27, 2026 at 12:20 AM.